🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)5mg → 10mg → 15mg titration — anyone have experience?

5mg → 10mg → 15mg titration — anyone have experience?

ChrisMacros Sat, Feb 28, 2026 at 12:13 PM 7 replies 785 viewsPage 1 of 2
ChrisMacros
Member
567
2,345
Sep 2024
Michigan
Feb 28, 2026 at 12:13 PM#1

Four dose steps in, holding each one the full four weeks, and I am trying to work out whether the interval is a pharmacological requirement or a tolerability convention.

The bit I cannot resolve on my own is why the interval is four weeks rather than two, and whether a slower ladder gets to the same place.

Numbers rather than impressions, if you have them.

20 23RunnerRach, TrialNerd_Beth, HPLC_Greg and 17 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Feb 28, 2026 at 12:44 PM#2

Answering the narrow version, because the broad one does not have a single answer. Four weeks is the pharmacokinetics, not caution. With a one-week half-life you need four to five half-lives to reach steady state, so at two weeks you are dosing on top of a concentration that has not finished rising. Escalating then stacks exposure and you get the side-effect burden of the higher dose before you have seen the benefit of the current one.

Last edited: Feb 28, 2026 at 1:44 PM
21 24mike_nyc, VendorMark, COA_Karl and 18 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Feb 28, 2026 at 1:15 PM#3
DataDave said:
Four weeks is the pharmacokinetics, not caution.

Agreed on the arithmetic, with one condition: holding indefinitely at a dose that is not doing anything is not patience, it is a stall with a nice name. The distinction is whether appetite has changed at all at the current step.

22 0RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 19 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Feb 28, 2026 at 1:46 PM#4
ChrisMacros said:
Four dose steps in, holding each one the full four weeks, and I am trying to work out whether the interval is a pharmacological requirement or a…

Same position here, arrived at the long way round. Holding longer is the underrated move. A step that is uncomfortable at week two is frequently comfortable at week six with no change in dose, because the gastric-emptying component tachyphylaxes while the appetite effect persists. Escalating at week two throws that adaptation away.

23 1MikeKY_noInsulin, Dr.RaviCardio, jennifer_SEA and 20 others
Reply Quote Save Share Report
chris_chi24
Member
389
1,678
Sep 2024
Chicago, IL
Feb 28, 2026 at 4:37 PM#5

From the other side of the consultation, briefly.

PSA for titration users considering the 0.25mg starting dose: this dose is NOT intended for weight loss. It's a titration dose to let your body adjust. Don't be discouraged if you don't lose much in the first month.

The therapeutic dose for weight management starts at 1.7mg (semaglutide) or 5mg (tirzepatide). Be patient with the ramp-up.

Last edited: Feb 28, 2026 at 7:37 PM
24 2SleepFixSam, PurityPaulOR, MaxMetOK and 21 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register